Daniel Shouval
Daniel Shouval is an expert in Hepatology at Hadassah Medical Center (Israel). As of February 2026, ScienceLeadR ranks Daniel Shouval in the top 1% of experts worldwide for Hepatitis, and in the top 1% of experts in Israel for Liver Neoplasms. Daniel Shouval has authored 280 publications, the most recent in 2025, and is an investigator in 4 clinical trials. SLR score: 1,033 (community average: 125). How the SLR is computed.
LeadR Profile
Hepatology
Subspecialties: Gastroenterology - Infectiology - Immunology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1973 - 2025
Number : 280
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| The Viral Hepatitis Prevention Board (VHPB) supports the continued recommendation for universal hepatitis B vaccination of all newborns within 24 hours of birth. PMID 41379456 — parturition, infant, newborn, vaccines, vaccination, hepatitis b, hepatitis | Hum Vaccin Immunother | 2025 | 0 |
| Longterm Outcome of Therapeutic Vaccination with a Third Generation Pre-S/S HBV Vaccine (PreHevbrio) of Chronically HBV Infected Patients. PMID 38672991 — vaccines, vaccination, therapeutics, infections | J Pers Med | 2024 | 6 |
| Hepatitis A virus infection. PMID 37770459 — vaccines, antibodies, hepatitis a virus, liver, vaccination, viruses, hepatitis a, infections, hepatitis, virus diseases | Nat Rev Dis Primers Top journal | 2023 | 38 |
| Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. PMID 37517414 — liver diseases, mothers, absenteeism, vaccines, vaccination, aged, work, prevalence, diagnosis, therapeutics, hepatitis b, gastrointestinal diseases, infections, hepatitis, child | Lancet Gastroenterol Hepatol Top journal | 2023 | 190 |
| Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries. PMID 37030400 — liver diseases, research design, hepatitis d, liver, reflex, viruses, prevalence, hepatitis b, infections, hepatitis | J Hepatol | 2023 | 39 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map